Clinical Trials
3 trialsNCT03860272 2026-03-30
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
Agenus Inc.
Phase 1 Active not recruiting
NCT05377528 2025-04-30
Study of AGEN1571 in Participants With Advanced Solid Tumors
Agenus Inc.
Phase 1 Completed
NCT04156100 2022-03-03
A Study in Subjects With Advanced Solid Tumors
Agenus Inc.
Phase 1 Terminated